-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
-
Summary
-
CRISPR Therapeutics AG quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q1 2016 to Q2 2024.
- CRISPR Therapeutics AG Weighted Average Number of Shares Outstanding, Basic for the quarter ending June 30, 2024 was 84.9M shares, a 7.37% increase year-over-year.
- CRISPR Therapeutics AG annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 79.2M shares, a 1.9% increase from 2022.
- CRISPR Therapeutics AG annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 77.7M shares, a 2.37% increase from 2021.
- CRISPR Therapeutics AG annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 75.9M shares, a 15.2% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)